Search results for: 'tech collaboration analysi'

This Frost Radar™ analysis investigates the healthcare platforms and tools that enhance communication and collaboration between care providers and payers for services, as well as the interfaces that connect payers and providers directly. The payer is often a private insurer, but could also be a patient or a government entity. As the industry transi...

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...

This report provides a comprehensive analysis of innovations and growth opportunities in the surgical visualization landscape, highlighting the evolution of image-guided navigation, AI-powered image fusion, and immersive visualization platforms. With the increasing traction towards minimally invasive surgeries and multimodal imaging, traditional 2D...

In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

Healthcare systems today are facing a convergence of pressures that threaten both operational stability and patient outcomes. Workforce shortages, clinician burnout, rising costs, and persistent health inequities are compounded by the growing demands of an aging population with complex needs.These challenges are not isolated—they interact and inten...

The increasing burden of neuropsychiatric conditions on healthcare systems and pharmacotherapy challenges including side effects, limited and delayed efficacy, and non-responsiveness calls for alternative solutions that are effective and easy to use. Neuromodulation devices use electrical or magnetic impulses to stimulate nerve activity. They can b...